Cullinan Oncology Ownership | Who Owns Cullinan Oncology?

Cullinan Oncology Ownership Summary

Cullinan Oncology is owned by 111.43% institutional investors, 4.50% insiders. Bioimpact capital is the largest institutional shareholder, holding 17.78% of CGEM shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.58% of its assets in Cullinan Oncology shares.

CGEM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cullinan Oncology	111.43%	4.50%	-15.93%
Sector	Healthcare Stocks	49.83%	8.81%	41.35%
Industry	Biotech Stocks	47.19%	8.79%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bioimpact capital	7.65M	17.78%	$133.39M
Bvf inc/il	5.75M	13.37%	$100.29M
Blackrock	3.55M	8.25%	$61.92M
Deerfield management company, l.p. (series c)	3.28M	7.63%	$57.21M
Vanguard group	2.87M	6.68%	$50.08M
Franklin resources	2.44M	5.68%	$42.63M
Adage capital partners gp	2.23M	5.19%	$38.94M
Blue owl capital lp	2.05M	4.76%	$35.74M
State street	1.94M	4.51%	$33.85M
Alliancebernstein	1.73M	4.02%	$30.15M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bioimpact capital	7.65M	20.73%	$133.39M
Blue owl capital lp	2.05M	9.94%	$35.74M
Foresite capital management v	657.90K	7.33%	$11.47M
Nextech invest	1.22M	3.58%	$21.30M
Bvf inc/il	5.75M	2.81%	$100.29M
Twin focus capital partners	595.49K	1.66%	$10.39M
Tang capital management	921.14K	1.64%	$16.06M
Vr adviser	1.38M	1.53%	$24.07M
Avidity partners management lp	1.56M	1.16%	$27.20M
Paradigm biocapital advisors lp	1.54M	1.03%	$26.91M

Top Buyers

Holder	Shares	% Assets	Change
Bvf inc/il	5.75M	2.81%	2.55M
Deerfield management company, l.p. (series c)	3.28M	0.95%	2.14M
Alliancebernstein	1.73M	0.01%	1.70M
Avidity partners management lp	1.56M	1.16%	1.56M
Vr adviser	1.38M	1.53%	1.38M

Top Sellers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	-	-	-1.13M
Braidwell lp	176.17K	0.10%	-1.06M
Blue owl capital lp	2.05M	9.94%	-875.67K
Perceptive advisors	-	-	-749.92K
Logos global management lp	-	-	-700.00K

New Positions

Holder	Shares	% Assets	Change	Value
Avidity partners management lp	1.56M	1.16%	1.56M	$27.20M
Vr adviser	1.38M	1.53%	1.38M	$24.07M
Holocene advisors, lp	1.32M	0.10%	1.32M	$22.95M
Artal group	1.06M	0.47%	1.06M	$18.45M
Rtw investments, lp	1.05M	0.28%	1.05M	$18.36M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-5.00
Advisor group	-50.00
Simplex trading	-119.00
Pacer advisors	-595.00
Newedge advisors	-723.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	142	3.65%	65,005,696	3.31%	111	0.85%	85	-14.14%	28	12.00%
Jun 30, 2024	136	18.26%	62,925,233	59.82%	146	1.73%	98	60.66%	25	-30.56%
Mar 31, 2024	115	1.77%	39,373,046	6.88%	92	1.24%	61	-11.59%	36	56.52%
Dec 31, 2023	113	6.60%	36,838,443	-3.03%	86	0.95%	69	50.00%	23	-25.81%
Sep 30, 2023	106	-0.93%	37,989,760	3.06%	95	1.16%	46	-11.54%	31	-18.42%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.50M	2.58%	2.18K
iShares Russell 2000 ETF	1.34M	2.30%	-3.01K
SPDR® S&P Biotech ETF	1.26M	2.18%	13.99K
AB Small Cap Growth A	839.90K	1.45%	19.55K
Franklin Biotechnology Discv A(acc)USD	842.14K	1.45%	-
Franklin US Small Cap Growth Equity	791.57K	1.37%	-8.13K
Franklin Small Cap Growth Adv	791.57K	1.37%	-
Vanguard Institutional Extnd Mkt Idx Tr	761.00K	1.31%	-2.53K
Franklin Biotechnology Discovery A	483.95K	0.83%	-21.00K
iShares Russell 2000 Growth ETF	407.14K	0.70%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 24, 2024	AHMED NADIM	President and CEO	Sell	$99.71K
Dec 18, 2024	Michaelson Jennifer	Chief Scientific Officer	Sell	$53.55K
Dec 18, 2024	Jones Jeffrey Alan	Chief Medical Officer	Sell	$52.85K
Dec 18, 2024	SUMER JACQUELYN L	Chief Legal Officer	Sell	$39.73K
Dec 12, 2024	Michaelson Jennifer	Chief Scientific Officer	Sell	$43.68K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	5
2024 Q3	-	2
2024 Q2	-	3
2024 Q1	-	5
2023 Q4	-	11

CGEM Ownership FAQ

Who Owns Cullinan Oncology?

Cullinan Oncology shareholders are primarily institutional investors at 111.43%, followed by 4.50% insiders and -15.93% retail investors. The average institutional ownership in Cullinan Oncology's industry, Biotech Stocks , is 47.19%, which Cullinan Oncology exceeds.

Who owns the most shares of Cullinan Oncology?

Cullinan Oncology’s largest shareholders are Bioimpact capital (7.65M shares, 17.78%), Bvf inc/il (5.75M shares, 13.37%), and Blackrock (3.55M shares, 8.25%). Together, they hold 39.41% of Cullinan Oncology’s total shares outstanding.

Does Blackrock own Cullinan Oncology?

Yes, BlackRock owns 8.25% of Cullinan Oncology, totaling 3.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.92M$. In the last quarter, BlackRock increased its holdings by 1.12M shares, a 46.16% change.

Who is Cullinan Oncology’s biggest shareholder by percentage of total assets invested?

Bioimpact capital is Cullinan Oncology’s biggest shareholder by percentage of total assets invested, with 20.73% of its assets in 7.65M Cullinan Oncology shares, valued at 133.39M$.

Who is the top mutual fund holder of Cullinan Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cullinan Oncology shares, with 2.58% of its total shares outstanding invested in 1.5M Cullinan Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools